Evidence map›Paper›PMID 38758251›Full record

ReviewAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2024

Optical lateral flow assays in early diagnosis of SARS-CoV-2 infection.

Rushi Liang, Aiping Fan, Feiqian Wang, Yajing Niu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rushi LiangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, People's Republic of China.
Aiping FanSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, People's Republic of China. fanap@tju.edu.cn.ORCID http://orcid.org/0000-0002-0875-710X
Feiqian WangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, People's Republic of China.
Yajing NiuBeijing Pharma and Biotech Center, Beijing, 100035, People's Republic of China. yajing.531@163.com.

Funding

National Natural Science Foundation of China 21475094
6 · The paper itself

Abstract

So far, the 2019 novel coronavirus (COVID-19) is spreading widely worldwide. The early diagnosis of infection by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is essential to provide timely treatment and prevent its further spread. Lateral flow assays (LFAs) have the advantages of rapid detection, simple operation, low cost, ease of mass production, and no need for special devices and professional operators, which make them suitable for self-testing at home. This review focuses on the early diagnosis of SARS-CoV-2 infection based on optical LFAs including colorimetric, fluorescent (FL), chemiluminescent (CL), and surface-enhanced Raman scattering (SERS) LFAs for the detection of SARS-CoV-2 antigens and nucleic acids. The types of recognition components, detection modes used for antigen detection, labels employed in different optical LFAs, and strategies to improve the detection sensitivity of LFAs were reviewed. Meanwhile, LFAs coupled with different nucleic acid amplification techniques and CRISPR-Cas systems for the detection of SARS-CoV-2 nucleic acids were summarized. We hope this review provides research mentalities for developing highly sensitive LFAs that can be used in home self-testing for the early diagnosis of SARS-CoV-2 infection.

Indexed as

COVID-19Early DiagnosisSARS-CoV-2Antigens, ViralColorimetryCOVID-19 TestingHumansLuminescent MeasurementsNucleic Acid Amplification TechniquesSpectrum Analysis, RamanAntigens, ViralAntigen detectionEarly diagnosisLateral flow assaysNucleic acid detectionSevere acute respiratory syndrome coronavirus-2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.